Tech Company Financing Transactions
Cell Care Therapeutics Funding Round
Cell Care Therapeutics closed a $4.3 million Seed funding round on 10/24/2018. Backers included private investors.
Transaction Overview
Company Name
Announced On
10/24/2018
Transaction Type
Venture Equity
Amount
$4,300,000
Round
Seed
Investors
Proceeds Purpose
This round of funding will be used to develop Cell Care's manufacturing platform and to advance its lead preclinical-stage drug candidate for major eye diseases, including diabetic retinopathy (DR) and neovascular age-related macular degeneration (wet AMD), two of the leading causes of vision loss and blindness in the developed world.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
750 Royal Oaks Dr. 106
Monrovia, CA 91016
USA
Monrovia, CA 91016
USA
Phone
Website
Email Address
Overview
Cell Care Therapeutics is a Los Angeles based preclinical stage company developing regenerative immunotherapies. This new class of biologics is derived from the secretions of adult stem cells and is comprised of a complex mixture of naturally therapeutic components including proteins, exosomes and microRNAs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicolas Sohl
Chief Scientific Officer
Rajashekhar Gangaraju
Browse more venture capital transactions:
Prev: 10/24/2018: K4Connect venture capital transaction
Next: 10/24/2018: Microbiotica venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs